GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Epi Biotech Co Ltd (XKRX:446440) » Definitions » Scaled Net Operating Assets

Epi Biotech Co (XKRX:446440) Scaled Net Operating Assets : (As of . 20)


View and export this data going back to 2023. Start your Free Trial

What is Epi Biotech Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Epi Biotech Co's operating assets for the quarter that ended in . 20 was ₩ Mil. Epi Biotech Co's operating liabilities for the quarter that ended in . 20 was ₩ Mil. Epi Biotech Co's Total Assets for the quarter that ended in . 20 was ₩ Mil. Therefore, Epi Biotech Co's scaled net operating assets (SNOA) for the quarter that ended in . 20 was .


Epi Biotech Co Scaled Net Operating Assets Historical Data

The historical data trend for Epi Biotech Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epi Biotech Co Scaled Net Operating Assets Chart

Epi Biotech Co Annual Data
Trend
Scaled Net Operating Assets

Epi Biotech Co Semi-Annual Data
Scaled Net Operating Assets

Competitive Comparison of Epi Biotech Co's Scaled Net Operating Assets

For the Biotechnology subindustry, Epi Biotech Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Epi Biotech Co's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Epi Biotech Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Epi Biotech Co's Scaled Net Operating Assets falls into.


;
;

Epi Biotech Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Epi Biotech Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in . 20 is calculated as

Scaled Net Operating Assets (SNOA)(A: . 20 )
=(Operating Assets (A: . 20 )-Operating Liabilities (A: . 20 ))/Total Assets (A: . 20 )
=(-)/
=

where

Operating Assets(A: . 20 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
= -
=

Epi Biotech Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in . 20 is calculated as

Scaled Net Operating Assets (SNOA)(Q: . 20 )
=(Operating Assets (Q: . 20 )-Operating Liabilities (Q: . 20 ))/Total Assets (Q: . 20 )
=(-)/
=

where

Operating Assets(Q: . 20 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
= -
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Epi Biotech Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Epi Biotech Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Epi Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
32, Songdogwahak-ro, Rooms 1903 and 1904, 15th floor, M-dong, Yeonsu-gu, Incheon, KOR, 21984
Epi Biotech Co Ltd is developing various pipelines for each hair loss treatment modality. It also conducts R&D in skin regeneration treatments to create commercially viable consumer products. The company specializes in hair loss treatment in Korea.

Epi Biotech Co Headlines

No Headlines